Carna Biosciences, Enamine to Collaborate in Research on Kinase.Tokyo, Japan, May 19, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Carna Biosciences has concluded a joint research agreement with Ukrainian pharmaceutical company Enamine en·a·mine n. An amine that contains the double bond linkage  C C .
Under the agreement terms, the two companies will strive to identify lead compounds against kinase kinase /ki·nase/ (ki´nas) 1. a subclass of the transferases, comprising the enzymes that catalyze the transfer of a high-energy group from a donor (usually ATP) to an acceptor. 2. targets. Specifically, Enamine will create a compound library of kinases, which are related to cancer. Carna Biosciences will screen the library, and identify and develop lead compounds. Lead compounds resulted from the collaboration Working together on a project. See collaborative software. effort will be licensed to other pharmaceutical companies. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion